journal article·2025-04-23Open access

Combating Concomitant Bacterial and Fungal Infections via Codelivery of Nitric Oxide and Fluconazole

Rashmi Pandey, Natalie Crutchfield, Mark Richard Stephen Garren, Ekaa Manohar Kasetty, Manjyot Kaur Chug, Elizabeth J. Brisbois, Hitesh Handa

ACS Applied Materials & Interfaces· Volume 17· Issue 16

Abstract

High Resolution Image Download MS PowerPoint Slide Device-associated infections are a major challenge for healthcare and cause patient morbidity and mortality as well as pose a significant economic burden. Infection-causing bacteria and fungi are equally notorious and responsible for biofilm formation and the development of antibiotic and antifungal-resistant strains. Biomaterials resisting bacterial and fungal adhesion can address device-associated infections more safely and efficiently than conventional systemic antibiotic therapies. Herein, we present a combination of potent antibacterial nitric oxide (NO) with antifungal fluconazole codelivery system from a polymeric matrix to combat bacterial and fungal infections simultaneously. The NO donor S -nitroso- N -acetyl-penicillamine (SNAP)-blended low-water-uptake polycarbonate urethane (TSPCU) was dip-coated with high-water-uptake polyether urethane (TPU) containing fluconazole to have an antibacterial and antifungal surface. The composites were characterized for surface wettability and coating stability using water contact angle (WCA) analysis. The real-time NO release (72 h) was evaluated using a chemiluminescence-based nitric oxide analyzer which showed physiologically relevant levels of NO released. The composites released fluconazole for 72 h under physiological conditions. Antibacterial analysis demonstrated a > 3-log reduction of viable Staphylococcus aureus and >2-log reduction of viable Escherichia coli compared to controls. The antifungal evaluation resulted in ∼98% reduction in adhered and ∼92% reduction in planktonic Candida albicans . The SNAP-fluconazole composites also showed biocompatibility against mouse fibroblast cells. This novel preventative strategy to combat bacterial and fungal infections may offer a promising tool for further translational research.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Analytical Chemistry and Sensors · Antimicrobial agents and applications · Antibiotics Pharmacokinetics and Efficacy

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemical, Materials, and Biomedical Engineering, College of Engineering

University of Georgia

Franklin College of Arts and Sciences

Pharmaceutical and Biomedical Science Department, College of Pharmacy

Funding

National Heart, Lung, and Blood Institute

References (68)

Show source-provided references
1. 10.1097/SHK.000000000000069210.1097/SHK.0000000000000692 ↗
2. 10.1016/j.suc.2011.11.00310.1016/j.suc.2011.11.003 ↗
3. 10.2147/IDR.S37950210.2147/IDR.S379502 ↗
4. 10.1128/IAI.72.10.6023-6031.200410.1128/IAI.72.10.6023-6031.2004 ↗
5. 10.1128/AAC.02659-1510.1128/AAC.02659-15 ↗
6. 10.15698/mic2020.06.71810.15698/mic2020.06.718 ↗
7. 10.2165/00003495-199039060-0000610.2165/00003495-199039060-00006 ↗
8. 10.1177/10600280900240091410.1177/106002809002400914 ↗
9. 10.1016/0002-9343(89)90481-610.1016/0002-9343(89)90481-6 ↗
10. 10.1093/clinids/14.4.95210.1093/clinids/14.4.952 ↗
11. 10.1016/j.jpeds.2005.02.02010.1016/j.jpeds.2005.02.020 ↗
12. 10.1097/00000658-200104000-0001010.1097/00000658-200104000-00010 ↗
13. 10.1590/S0100-879X200200070000510.1590/S0100-879X2002000700005 ↗
14. 10.3389/fmicb.2015.0066910.3389/fmicb.2015.00669 ↗
15. 10.1016/j.ijbiomac.2024.12962110.1016/j.ijbiomac.2024.129621 ↗
16. 10.1016/j.ijbiomac.2023.12897810.1016/j.ijbiomac.2023.128978 ↗
17. 10.2174/13894500677855911110.2174/138945006778559111 ↗
18. 10.1039/c2cs15273h10.1039/c2cs15273h ↗
19. 10.1515/hsz-2019-036810.1515/hsz-2019-0368 ↗
20. 10.1172/JCI11947310.1172/JCI119473 ↗
21. 10.1016/j.bsbt.2015.08.00310.1016/j.bsbt.2015.08.003 ↗
22. 10.1016/j.niox.2012.02.00210.1016/j.niox.2012.02.002 ↗
23. 10.1038/jid.2009.9510.1038/jid.2009.95 ↗
24. 10.1002/mabi.20200024810.1002/mabi.202000248 ↗
25. 10.1021/acsami.1c1724810.1021/acsami.1c17248 ↗
26. 10.1002/jbm.a.3749310.1002/jbm.a.37493 ↗
27. 10.1021/acsami.1c0133010.1021/acsami.1c01330 ↗
28. 10.1099/13500872-145-7-164110.1099/13500872-145-7-1641 ↗
29. 10.1128/AAC.42.9.234210.1128/AAC.42.9.2342 ↗
30. 10.1021/acs.jmedchem.3c0130810.1021/acs.jmedchem.3c01308 ↗
31. 10.1371/journal.pone.017675510.1371/journal.pone.0176755 ↗
32. 10.1016/j.actbio.2022.11.00610.1016/j.actbio.2022.11.006 ↗
33. 10.1038/nm0695-55210.1038/nm0695-552 ↗
34. 10.1128/iai.64.8.3127-3133.199610.1128/iai.64.8.3127-3133.1996 ↗
35. 10.1016/j.biomaterials.2013.05.06310.1016/j.biomaterials.2013.05.063 ↗
36. 10.1021/acsami.5b0750110.1021/acsami.5b07501 ↗
37. 10.1039/C6BM00948D10.1039/C6BM00948D ↗
38. 10.1016/j.jconrel.2009.09.01110.1016/j.jconrel.2009.09.011 ↗
39. 10.1021/jp053110710.1021/jp0531107 ↗
40. 10.1039/c2cs15271a10.1039/c2cs15271a ↗
41. 10.1021/acsami.4c0236910.1021/acsami.4c02369 ↗
42. Standard I. · 2009
43. 10.1021/acsmacrolett.7b0044810.1021/acsmacrolett.7b00448 ↗
44. 10.1002/jbm.a.3110310.1002/jbm.a.31103 ↗
45. 10.1016/j.jcis.2023.09.18810.1016/j.jcis.2023.09.188 ↗
46. 10.3390/pharmaceutics1111055010.3390/pharmaceutics11110550 ↗
47. 10.1016/j.niox.2019.08.00210.1016/j.niox.2019.08.002 ↗
48. 10.1016/j.porgcoat.2020.10568110.1016/j.porgcoat.2020.105681 ↗
49. 10.1002/jbm.a.3065710.1002/jbm.a.30657 ↗
50. 10.1038/s41598-017-14012-910.1038/s41598-017-14012-9 ↗
51. 10.1039/C6BM00271D10.1039/C6BM00271D ↗
52. 10.3390/antiox811055610.3390/antiox8110556 ↗
53. 10.1152/ajpheart.1998.274.6.H216310.1152/ajpheart.1998.274.6.H2163 ↗
54. 10.1021/acsami.2c0230110.1021/acsami.2c02301 ↗
55. 10.1021/acsbiomaterials.9b0073710.1021/acsbiomaterials.9b00737 ↗
56. 10.1021/acsami.8b0864710.1021/acsami.8b08647 ↗
57. 10.1093/ofid/ofab59310.1093/ofid/ofab593 ↗
58. 10.1056/NEJMoa130680110.1056/NEJMoa1306801 ↗
59. 10.1111/apm.1332410.1111/apm.13324 ↗
60. 10.1093/ndt/gfg36310.1093/ndt/gfg363 ↗
61. ASTM E3371-22 · 2022
62. 10.3390/jcm1111320410.3390/jcm11113204 ↗
63. 10.1021/acsabm.9b0023710.1021/acsabm.9b00237 ↗
64. 10.1016/j.jcis.2024.03.08210.1016/j.jcis.2024.03.082 ↗
65. 10.1021/acsami.1c0892110.1021/acsami.1c08921 ↗
66. 10.1099/00221287-148-10-293710.1099/00221287-148-10-2937 ↗
67. 10.1016/j.cis.2020.10223010.1016/j.cis.2020.102230 ↗
68. 10.1016/j.colsurfb.2018.12.02510.1016/j.colsurfb.2018.12.025 ↗